Michigan Angel Summit
Investing in Michigan’s economy.
Monday, October 4 | 9 a.m. – 4 p.m.
Sheraton Ann Arbor
3200 Boardwalk Dr.
$150 per ticket
$50 per ticket
The fourth annual Michigan Angel Summit has valuable information for people considering angel investing and those who have been investing in entrepreneurs and startups for years.
We’re pleased to welcome our keynote guests, Scott Shane of Comeback Capital and Commissioner Hester M. Peirce of the U. S. Security and Exchanges Commissions.
- Scott Shane is an economist at Case Western, an angel investor, and the managing director of Comeback Capital.
- Prior to joining the SEC, Commissioner Peirce conducted research on the regulation of financial markets at the Mercatus Center at George Mason University.
“Angel investment activity in Michigan has continued to increase in recent years, both in terms of companies attracting angel investment and individuals choosing to invest their wealth in emerging businesses. The Michigan Angel Summit is the opportunity to hear about that activity and also to learn about how angel investing works, both for early stage companies as well as people interested in learning about why it’s an attractive investment activity.” — Skip Simms, Ann Arbor SPARK senior vice president and managing director of the Michigan Angel Community
Your Michigan Angel Summit ticket purchase includes free admission to the Invest360: Information Technology following the summit from 4:00 – 6:00 p.m. This is the first of three Invest360 sessions (Information Technology, Mobility, and Healthcare) happening throughout the week. Learn more about Invest360.
This event is presented by Ann Arbor SPARK.
2021 Keynote Speakers
Scott Shane is managing director of Comeback Capital, a pre-seed stage venture capital fund that invests across the Midwest, now on its second and third funds. He is also a deal flow partner for Right Side Capital Management, a San Francisco-based pre-seed stage micro VC fund, and an advisor to Ivy Cap Ventures, a $150M Indian venture capital fund. He is an active angel and limited partner and mentor at the Iconyc, Acceleprise, and gener8tor accelerator funds, and an LP in Refinery Ventures and Illuminate Ventures.
He was the A. Malachi Mixon III Professor of Entrepreneurial Studies at Case Western Reserve University from 2006-20021. The author of 92 scholarly articles and 12 books, Dr. Shane was the 2009 winner of the Global Award for Entrepreneurship Research, the most prestigious award in this academic field. According to a study by John Ioannidis at Stanford University, published in PLoS Biology, Dr. Shane is the 1,137th most impactful scientist out of seven million living scientists.
Dr. Shane has also written extensively for popular audiences, penning regular columns for Bloomberg Businessweek, Inc., Entrepreneur, and the New York Times. Dr. Shane has served on the faculty at the University of Maryland, Massachusetts Institute of Technology, and Georgia Institute of Technology, and as a visiting scholar at the Federal Reserve Bank of Cleveland. He serves currently as an advisor to the Youngstown Business Incubator, the Veale Institute for Entrepreneurship, and several startup companies. Dr. Shane received his Ph.D. in Applied Economics from the Wharton School of the University of Pennsylvania.
Commissioner Hester M. Peirce
U.S. Securities and Exchange Commission
Commissioner Hester M. Peirce
U.S. Securities and Exchange Commission
Hester M. Peirce was appointed by President Donald J. Trump to the U.S. Securities and Exchange Commission and was sworn in on January 11, 2018.
Prior to joining the SEC, Commissioner Peirce conducted research on the regulation of financial markets at the Mercatus Center at George Mason University. She was a senior counsel on the U.S. Senate Committee on Banking, Housing, and Urban Affairs, where she advised Ranking Member Richard Shelby and other members of the Committee on securities issues. Commissioner Peirce served as counsel to SEC Commissioner Paul S. Atkins. She also worked as a staff attorney in the SEC’s Division of Investment Management. Commissioner Peirce was an associate at Wilmer, Cutler & Pickering (now WilmerHale) and clerked for Judge Roger Andewelt on the Court of Federal Claims.
Commissioner Peirce earned her bachelor’s degree in Economics from Case Western Reserve University and her JD from Yale Law School.
Panelists, Guests, and Moderators
Dr. Dawn Batts has over two decades of experience, analyzing business opportunities, developing and implementing strategic plans, and managing their subsequent operations and compliance processes. Her diverse professional experiences and extensive research have led to her solutions-based approach in addressing the myriad of factors causing the economic disparity between women and men. Dawn’s research investigates how macro narratives influence women’s perceptions and experiences of gender equality in the United States and China.
As a Capital Strategist for Tech Town — Detroit’s entrepreneurship hub — Dawn secures and aligns resources that help Detroit-based entrepreneurs achieve the vision and goals of their businesses. She extends that work as co-founder of Commune Angels, a diverse community of investors who seed scalable consumer, enterprise, and life science companies that transform lives.
Dawn received a B.A. in Accounting from Michigan State University, her MBA from the Ross School of Business at the University of Michigan, and her Ph.D. in Anthropology from Wayne State University.
Matt is a partner with Varnum LLP and serves as outside general counsel to a wide range of emerging and middle market companies. His particular industry concentrations include software, SaaS, information technology, IoT, data analytics, and other technology-based companies, as well as manufacturing, automotive, advanced materials, pharma, medical devices, publishing, digital advertising and media, retail, and food and beverage.
Matt’s emerging companies practice focusses on capital fundraising, including SAFE financing, convertible debt, preferred equity financing, as well as securities law compliance. He works closely with companies from cradle (formation and organization) to liquidity (sale or merger) and all stages of development in between. Matt’s experience in the early-stage capital markets includes fund representation, fund formation, and investments.
Matt is a member of Varnum’s Business and Corporate Services Practice Team and participates in the Intellectual Property, the Data Privacy and Cybersecurity, and the Startup and Emerging Companies practice teams. He is also the lead partner of the firm’s Ann Arbor office.
Institute for Entrepreneurial Leadership Inc
Institute for Entrepreneurial Leadership Inc
Jill Johnson is the co-founder and CEO of the Institute for Entrepreneurial Leadership (IFEL), based in Newark, NJ. IFEL, founded in 2002, is an independent, not‐for‐profit organization that supports economic development through entrepreneurship. With over 30 years of experience as a business strategist, Jill is a pioneering voice for inclusive entrepreneurial ecosystems and is especially focused on creating a new paradigm for the access to capital conversation. Most recently, Jill conceived and launched the Women of Color Connecting initiative to change the way we think about building the capacity of Women of Color entrepreneurs for the grow-scale-exit trajectory. She is also spearheading The Making of Black Angels movement to drive diversity and inclusion within the angel investing sector.
Jill started her career as a financial analyst at Goldman, Sachs & Co in mergers and acquisitions where she worked across industries groups to help clients execute deals at a minimum transaction value of $100 million. Following her time at Goldman, Sachs, she joined the family business, City News Publishing Company. There she was responsible for advertising, sales, and strategic partnerships for YES Magazine, a national youth magazine circulated in schools and organizations in over 30 states. After being promoted to Associate Publisher of YES Magazine, she added production oversight to her list of management responsibilities. In her next professional experience and immediately prior to launching IFEL, Jill was the President of On Point Consulting, a strategic business planning consultancy. In that capacity, she advised early-stage businesses through a variety of strategic planning and growth issues.
In her capacity as CEO of the Institute for Entrepreneurial Leadership, Jill is responsible for the strategic direction of the organization and capacity building. She is especially focused on creating earned revenue opportunities and strategic partnerships. She has led the organization in successfully winning contracts with the New Jersey Department of Labor, the Newark Urban Enterprise Zone, Rutgers Center for Urban Entrepreneurship and Economic Development, and Greater Newark LISC to provide entrepreneurial training and support services.
Jill is a member of the Women’s Forum of New York, the Women Business Collaborative, and Harvard Alumni Entrepreneurs. She also serves on the board of the Horizon Foundation for New Jersey. She recently served on the NJ Restart & Recovery Advisory Council Main Street Committee. In the past, she served on the Red Tape Commission created by New York City Comptroller Scott Stringer and was an appointee of Mayor Cory Booker to the Board of Trustees of the Newark Public Library. She has also served as a co-chair of the South Orange Main Street Economic Development Committee.
Jill has a B.A. in economics from Harvard University and is married with four amazing sons.
Priya Gogoi is an entrepreneur, social change-maker, and author with published work in national media. She co-founded Celsee, Inc., in 2010, a life-science tools company developing products for cancer research and single-cell sequencing. In April 2020, BioRad Laboratories acquired Celsee for $165MM. Priya recently graduated with an Executive MBA from Ross, UofM, adding to her Master’s degree in Molecular Biology. She specializes in due diligence on Biotech startups, which involves technical due diligence, IP and competitive landscape, operations, and team efficiency. She also mentors several Ann Arbor area startups in preparing their Business Plans. Currently, Priya serves as a Board member in several local and international nonprofits and a contributing author in the national publication: Entrepreneur media.
Dr. Kalyan Handique
Dr. Kalyan Handique
Dr. Kalyan Handique is currently the Vice President, Advanced Technologies at BioRad, a billion-dollar company and a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life sciences and clinical diagnostics markets. Kalyan joined BioRad through the acquisition of Celsee, an innovative start-up he joined in 2011 in single cell analysis and rare cell diagnostics. Celsee was based in Ann Arbor, Michigan and acquired by BioRad in April 2020. Prior to Celsee, Kalyan served as the VP of R&D Systems Development for BD Diagnostics from 2009-2011. Kalyan ended up working for BD because of the acquisition of HandyLab in 2009. Kalyan co-founded HandyLab out of his Ph.D. work at the University of Michigan in 2000. HandyLab developed integrated microfluidic platforms for “sample-to-real time PCR results” for a dozen of FDA-approved infectious diseases for the hospitals and clinical labs. Kalyan received his Ph.D. in Chemical Engineering from the University of Michigan in 2000 and received a bachelor’s in chemical engineering from IIT Bombay in 1995. Kalyan is active in the entrepreneurial community and serves as an adviser and board member to many startups and technological organizations in the Michigan biotech region.
Toronto Stock Exchange
U.S. Capital Formation
George is currently the Vice President of U.S. Capital Formation based in Chicago and leading the business development efforts for the TSX & Venture Exchange across the Midwest. In his role, George partners with and helps U.S.-based companies to access the Canadian capital markets and raise public venture capital. Previously, George led the marketing & business development for a growing FinTech startup called owl.co and before that led the business development for Canada’s #1 mid-market tech-focused M&A firm called Sampford Advisors. On the side, George hosts a top-200 entrepreneurship-focused podcast called Let’s Grab Coffee, with more than 100 episodes published to date.
Joe Morrison, Jr.
Joseph R. (Joe) Morrison, Jr., represents high-growth companies in an outside general counsel capacity. He focuses on emerging companies that leverage technology to build their business and brand. He also represents venture capital firms and high net worth individuals that invest in high-growth companies. His business and technology background gives him the ability to deftly advise ambitious entrepreneurs facing legal and business challenges.
Joe has experience negotiating a wide range of financing transactions, including venture investment rounds, and company sale transactions. He also assists companies with their general operational concerns ranging from negotiating leases and customer or supplier contracts to intellectual property licensing to employment issues. He represents dozens of companies that have licensed technology from University Tech Transfer offices.
Before joining Bodman, Joe worked for Accenture as an information technology consultant in Washington, D.C. He also served as corporate counsel and consulting manager for a Michigan-based IT startup, where he helped scale the company to 50+ employees and $3 million in revenue.
Joe is active in the Ann Arbor startup scene and regularly presents to student and local startup groups and University of Michigan classes on legal issues facing young, high growth companies .
Joe serves on the board of directors of New Enterprise Forum in Ann Arbor. He is a member of the Institute of Continuing Legal Education (ICLE) Business Law Advisory Board and New Lawyers Advisory Board. He is listed in Michigan Rising Stars 2021 under Business/Corporate.
Espervita Therapeutics, Inc.
Espervita Therapeutics, Inc.
Roger Newton has worked for 40+ years in the pharmaceutical and biotech life sciences industries. He is formerly the executive chairman and CSO, and also founder, president/CEO, and director of Esperion Therapeutics, Inc., which has its business offices in Ann Arbor. Prior to these appointments, Roger was senior vice president, Pfizer Global R&D, and director, Esperion Therapeutics, a Pfizer, Inc. company.
He was co-founder, president/CEO of the original Esperion founded in July 1998. Under Roger’s leadership and the team’s effort, Esperion built a portfolio of mechanism-based biopharmaceuticals focusing on HDL therapy and small molecule lipid regulating agents. Esperion was acquired by Pfizer for $1.3 billion in February 2004 (13x cash on cash return) and operated as a separate unit within Pfizer until its closure in May 2007. Pfizer then divested Esperion in May 2008 and Roger restarted the company as an independent enterprise.
Roger and the Esperion team raised enough equity financing and venture capital to develop Nexletol (bempedoic acid) from preclinical to FDA approval in February 2020. Nexletol is a novel, oral LDL-cholesterol (LDL-C) lowering drug, which lowers LDL-C by an average of 18% without an increased risk of muscle pain and weakness as observed with statin drugs. Nexletol can be used with statins in patients who cannot reach their LDL-C goal because of muscle pain and weakness at higher doses. Bempedoic acid in combination with ezetimibe (Nexlizet), which also received FDA approval in February 2020, can be used to produce an average of 38% lowering of LDL-C. Prior to founding the original Esperion, Roger was with Warner Lambert/Parke-Davis from 1981-1998. As a Distinguished Research Fellow and Chairman of the Atherosclerosis Drug Discovery Team, he co-discovered and was the product champion of what is now the largest selling and most prescribed cholesterol-reducing drug in the world, atorvastatin (Lipitor®).
Roger began his career as a translational basic scientist with a focus on treating and preventing atherosclerosis (Cholesterol and Lipoprotein Metabolism) during his postdoctoral fellowship at the University of California San Diego at LaJolla. Roger has a Ph.D. in Nutrition Science (Lipid Metabolism) from the University of California, Davis, a Master of Science degree (Nutritional Biochemistry) from the University of Connecticut, and a Bachelor of Science degree with honors in Biology from Lafayette College. During his research career, he has co-authored over one hundred peer-reviewed scientific articles and chapters.
Roger serves or has served as a member of the Board of Directors of Espervita, Esperovax, and Esperion Therapeutics, Celsee Diagnostics, Swift Biosciences, and Rubicon Genomics. He has also served as President and Board Director of the American College of Nutrition, and a member of the National Advisory Boards of the University of Michigan Cardiovascular Center, Life Sciences Institute, and Taubman Medical Research Institute. Roger also currently participates as an Executive-in-Residence in the Center for Positive Organizations in the Ross School of Business at the University of Michigan interacting with students, staff, faculty, and alumni.
Ann Arbor SPARK
Ann Arbor SPARK
Skip Simms joined Ann Arbor SPARK in 2006 as Director of Entrepreneurial Services and was its second employee. In 2011, he was named Senior Vice President. Skip oversees all the entrepreneurial activities including incubators, business accelerator programs, and all capital programs.
He was the architect of the Michigan Pre-Seed Capital Fund co-investment program, the multiple microloan programs managed by SPARK, and the MI Innovation Equipment Depot. His newest initiative is the Michigan Angel Fund.
Skip has nearly fifteen years of experience in financing and investments. Prior to joining Ann Arbor SPARK, he was the Managing General Partner at the Ralph Wilson Equity Fund, a $31 million fund-of-funds.
Skip was a charter member of the Michigan Venture Capital Association and currently serves on their Board of Directors. He is a past board member of the New Enterprise Forum. You may have seen him at an entrepreneur event or program, as he is often asked to serve on panels or make presentations regarding start-up funding.
Chris Sing, CPA, CGMA, MBA
Chris is a principal in Rehmann’s Ann Arbor office. Chris also leads the firm’s emerging companies and cannabis practice groups and is a former member of the firm’s board of directors. She has 25 years of experience in public accounting at local and national firms, as well as executive experience in private industry. Chris serves as a close confidant and trusted advisor to her clients. She especially enjoys steering emerging companies through rapid stages of growth and partners closely with her clients through their critical milestones and transactions.
Erik Schumacher, CPA
Erik strives to help his clients effectively manage their tax obligations, whether through effective annual tax planning or transactional assistance. His client-focused service approach centers on consistent communication, effectively managing deadlines, and providing proactive solutions.
As a member of Rehmann’s cannabis industry group and private equity practice, Erik provides insight and leadership to these teams.
Erik has experience serving a broad range of clients across multiple industries, including the cannabis, energy, manufacturing, and private equity sectors. He also has substantial experience serving clients with complex equity structures often associated with private equity or foreign ownership.
Prior to joining Rehmann in 2018, Erik provided tax services with a large national firm, providing tax consulting and compliance services to large companies with international and private equity ownership. He also served as the director of tax for the firm’s local office.
Serial Angel Investor
Weathershield, L.L.C. (Chair), Eagle River Homes L.L.C. (Chair), Nanocerox, Inc. (Chair), and Muskingum University. Former Chairman, CEO & President, Champion Enterprises, Inc. and former President, The Henley Group
Walt Young has over 50 years of experience in leading organizations. For the first 36 years, he held senior positions at four public companies: BF Goodrich, The Budd Company, The Henley Group, and Champion Enterprises. As Chair and CEO of Champion (Fortune 500) Walt was recognized by Fortune as a “Superstar” and by the Harvard Business School as one of the 19 top business leaders of the 1990s. While at these four companies he completed 23 different turnarounds and over 75 mergers and acquisitions. Since 2003 Walt has focused on entrepreneurial start-ups, including as a lead investor and Director for Accuri Cytometers (acquired by Becton, Dickinson for in 2011), CelSee, Inc. (acquired by BioRad in 2020), and Swift Biosciences, Inc. (acquired by Danaher in 2021). He has led and assisted over 100 entities to raise more than $130M in capital. Walt is currently on the board of three early stage companies: Eagle River Homes, Weathershield, and Nanocerox, Inc.. From 2003 to 2018, Walt was a director at NRG Energy (NYSE:NRG, Fortune 200). Further, his non-profit boards have included Muskingum University, Oakland University and Gleaners Food Bank of Southeast Michigan.
Walt received a BA in History and Economics from Muskingum University, his MBA in Marketing and Management from Penn State University, and an honorary doctorate in Public Service from Muskingum University.
Michigan Angel Summit: Agenda
9:00 a.m. – 9:10 a.m.
Skip Simms, Manager of the Michigan Angel Community, the Michigan Angel Fund and Sr. Vice President of Ann Arbor SPARK
9:10 a.m. – 10:00 a.m.
Scott Shane, Managing Director | Comeback Capital
- Scott is an economist and was the A. Malachi Mixon III Professor of Entrepreneurial Studies at Case Western Reserve University from 2006-20021. The author of 92 scholarly articles and 12 books, Dr. Shane was the 2009 winner of the Global Award for Entrepreneurship Research, the most prestigious award in this academic field.He is an angel investor and Managing Director of Comeback Capital, a pre-seed stage venture capital fund that invests across the Midwest.
When is a SAFE Note Not a SAFE Note?
10:00 a.m. – 10:50 a.m.
Chris Sing, Partner | Rehmann
Erik Schumacher | Rehmann
- Let the debate begin. Which is better for the investor, a SAFE or traditional convertible note?
Celsee Case Study
11:00 a.m. – 11:50 a.m.
Kalyan Handique, Founder | Celsee
Walt Young | Investor
Roger Newton | Esperion Therapeutics
Priya Gogoi | Celsee
- In April 2020, Bio-Rad Laboratories, a global leader of life science research and clinical diagnostic products, acquired Celsee, Inc., an Ann Arbor company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Celsee was founded by serial entrepreneur Kalyan Handique.
11:00 a.m. – 11:50 a.m.
George Khalife, Vice President of Capital Formation | Toronto Stock Exchange
- This panel will explain how U.S. companies can go public in Canada on TSX or TSX Venture Exchange, a unique funding platform for high-growth companies looking to raise Series A & beyond. The panel will also share best practices and considerations on what companies can do today to get prepared for a go-public event down the road.
12 p.m. – 12:50 p.m.
Hester M. Peirce, Commissioner | U. S. Security and Exchanges Commission (SEC)
- Hester M. Peirce was appointed by President Donald J. Trump to the U.S. Securities and Exchange Commission and was sworn in on January 11, 2018. Prior to joining the SEC, Commissioner Peirce conducted research on the regulation of financial markets at the Mercatus Center at George Mason University. She was a Senior Counsel on the U.S. Senate Committee on Banking, Housing, and Urban Affairs, where she advised Ranking Member Richard Shelby and other members of the Committee on securities issues. Commissioner Peirce served as counsel to SEC Commissioner Paul S. Atkin. Commissioner Peirce earned her bachelor’s degree in Economics from Case Western Reserve University and her JD from Yale Law School. The Commissioner will give a broad overview of current SEC rules and regulations as they relate to early stage investors and then ask questions of the audience as to what is important to them.
10 Mistakes Angels Make, from an attorneys perspective
1 p.m. – 1:50 p.m.
Matt Bower, Partner | Varnum
Joe Morrison | Bodman
- When conducting their legal due diligence your attorney finds many mistakes that investors make leading up to a funding round or exit. This presentation is about the common mistakes angels make from investment structures to board responsibility, or IP ownership.
Groups Vs. Going it Alone
1 p.m. – 1:50 p.m.
Moderated by Dale Grogan, Executive Director | Angel Capital Network
- This panel will review the benefits of joining and investing through angel groups.
Diversity Boosts Returns
2 p.m. – 2:50 p.m.
Dr. Dawn Batts | Commune Angels
Jill Johnson | The Making of Black Angels
Dr. Marlo Rencher | TechTown Detroit
- Teams of diverse founders (more than one gender and/or more than one race or ethnicity represented) create more innovation and—on average—better financial outcomes, including 30 percent higher multiples on invested capital. Build a portfolio that will maximize your return through diversity of entrepreneurs and investors.
IP — Do You Have Enough?
3 p.m. – 3:50 p.m.
3:50 p.m. – 4:00 p.m.
Skip Simms, Senior Vice President | Ann Arbor SPARK
Invest360: Information Technology
4 p.m. – 6 p.m.